Skip to main content

Murphy Andrew J's Form 4 filing

Regeneron Pharmaceuticals, Inc. (REGN) · filed Dec 10, 2021

Accession no.
0001708138-21-000098
Filed
Dec 10, 2021
Trade date
Dec 8-10, 2021
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 19 non-derivative transactions and 2 derivative transactions. Open-market sales total $4.75M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Murphy Andrew JCIK 0001796226Officer (EVP Research)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 8, 2021Common StockAGrant or awardAcquired+3,462$0.00$059,167Direct
Dec 9, 2021Common StockMOption exerciseAcquired+16,500$52.03+$858,49575,667Direct
Dec 9, 2021Common StockFTax withholdingDisposed−9,378$657.11−$6,162,377.5866,289Direct
Dec 10, 2021Common StockSSaleDisposed−399$657.61F3−$262,386.3965,890Direct
Dec 10, 2021Common StockSSaleDisposed−330$658.78F4−$217,397.465,560Direct
Dec 10, 2021Common StockSSaleDisposed−370$659.29F5−$243,937.365,190Direct
Dec 10, 2021Common StockSSaleDisposed−4$660.45F6−$2,641.865,186Direct
Dec 10, 2021Common StockSSaleDisposed−282$661.57F7−$186,562.7464,904Direct
Dec 10, 2021Common StockSSaleDisposed−354$662.36F8−$234,475.4464,550Direct
Dec 10, 2021Common StockSSaleDisposed−272$663.61F9−$180,501.9264,278Direct
Dec 10, 2021Common StockSSaleDisposed−158$664.28F10−$104,956.2464,120Direct
Dec 10, 2021Common StockSSaleDisposed−404$665.29F11−$268,777.1663,716Direct
Dec 10, 2021Common StockSSaleDisposed−384$666.40F12−$255,897.663,332Direct
Dec 10, 2021Common StockSSaleDisposed−280$667.50F13−$186,90063,052Direct
Dec 10, 2021Common StockSSaleDisposed−1,738$668.42F14−$1,161,713.9661,314Direct
Dec 10, 2021Common StockSSaleDisposed−1,018$669.60F15−$681,652.860,296Direct
Dec 10, 2021Common StockSSaleDisposed−872$670.68F16−$584,832.9659,424Direct
Dec 10, 2021Common StockSSaleDisposed−219$671.33F17−$147,021.2759,205Direct
Dec 10, 2021Common StockSSaleDisposed−38$672.30−$25,547.459,167Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 9, 2021Common StockMOption exerciseDisposed−16,500$0.00$00Direct
Dec 8, 2021Common StockAGrant or awardAcquired+14,783$0.00$014,783Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F3

Represents volume-weighted average price of sales of 399 shares of Company stock on December 10, 2021 at prices ranging from $657.27 to $657.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F4

Represents volume-weighted average price of sales of 330 shares of Company stock on December 10, 2021 at prices ranging from $658.02 to $658.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F5

Represents volume-weighted average price of sales of 370 shares of Company stock on December 10, 2021 at prices ranging from $659.29 to $659.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F6

Represents volume-weighted average price of sales of 4 shares of Company stock on December 10, 2021 at prices ranging from $660.38 to $660.47. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F7

Represents volume-weighted average price of sales of 282 shares of Company stock on December 10, 2021 at prices ranging from $661.27 to $661.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F8

Represents volume-weighted average price of sales of 354 shares of Company stock on December 10, 2021 at prices ranging from $662.06 to $662.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F9

Represents volume-weighted average price of sales of 272 shares of Company stock on December 10, 2021 at prices ranging from $663.14 to $663.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F10

Represents volume-weighted average price of sales of 158 shares of Company stock on December 10, 2021 at prices ranging from $664.06 to $664.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F11

Represents volume-weighted average price of sales of 404 shares of Company stock on December 10, 2021 at prices ranging from $665.03 to $665.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F12

Represents volume-weighted average price of sales of 384 shares of Company stock on December 10, 2021 at prices ranging from $666.06 to $666.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F13

Represents volume-weighted average price of sales of 280 shares of Company stock on December 10, 2021 at prices ranging from $667.01 to $667.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F14

Represents volume-weighted average price of sales of 1,738 shares of Company stock on December 10, 2021 at prices ranging from $668.10 to $668.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F15

Represents volume-weighted average price of sales of 1,018 shares of Company stock on December 10, 2021 at prices ranging from $669.03 to $669.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F16

Represents volume-weighted average price of sales of 872 shares of Company stock on December 10, 2021 at prices ranging from $670.11 to $670.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F17

Represents volume-weighted average price of sales of 219 shares of Company stock on December 10, 2021 at prices ranging from $671.19 to $671.39. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)